rs75082326
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001846.4(COL4A2):c.1079-74A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.343 in 1,391,932 control chromosomes in the GnomAD database, including 85,775 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.28 ( 6996 hom., cov: 32)
Exomes 𝑓: 0.35 ( 78779 hom. )
Consequence
COL4A2
NM_001846.4 intron
NM_001846.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -6.24
Publications
4 publications found
Genes affected
COL4A2 (HGNC:2203): (collagen type IV alpha 2 chain) This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. The C-terminal portion of the protein, known as canstatin, is an inhibitor of angiogenesis and tumor growth. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. [provided by RefSeq, Jul 2008]
COL4A2 Gene-Disease associations (from GenCC):
- porencephaly 2Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- COL4A1 or COL4A2-related cerebral small vessel diseaseInheritance: AD Classification: MODERATE Submitted by: Illumina
- familial porencephalyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 13-110449605-A-G is Benign according to our data. Variant chr13-110449605-A-G is described in ClinVar as Benign. ClinVar VariationId is 1241514.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.372 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| COL4A2 | NM_001846.4 | c.1079-74A>G | intron_variant | Intron 18 of 47 | ENST00000360467.7 | NP_001837.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.279 AC: 42334AN: 151988Hom.: 6992 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
42334
AN:
151988
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.351 AC: 434702AN: 1239826Hom.: 78779 AF XY: 0.351 AC XY: 213992AN XY: 608806 show subpopulations
GnomAD4 exome
AF:
AC:
434702
AN:
1239826
Hom.:
AF XY:
AC XY:
213992
AN XY:
608806
show subpopulations
African (AFR)
AF:
AC:
2645
AN:
27374
American (AMR)
AF:
AC:
4126
AN:
21936
Ashkenazi Jewish (ASJ)
AF:
AC:
5253
AN:
20590
East Asian (EAS)
AF:
AC:
9205
AN:
34308
South Asian (SAS)
AF:
AC:
22584
AN:
67404
European-Finnish (FIN)
AF:
AC:
18988
AN:
46758
Middle Eastern (MID)
AF:
AC:
1037
AN:
5130
European-Non Finnish (NFE)
AF:
AC:
354464
AN:
964606
Other (OTH)
AF:
AC:
16400
AN:
51720
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
11868
23737
35605
47474
59342
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
11132
22264
33396
44528
55660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.278 AC: 42335AN: 152106Hom.: 6996 Cov.: 32 AF XY: 0.279 AC XY: 20766AN XY: 74338 show subpopulations
GnomAD4 genome
AF:
AC:
42335
AN:
152106
Hom.:
Cov.:
32
AF XY:
AC XY:
20766
AN XY:
74338
show subpopulations
African (AFR)
AF:
AC:
4499
AN:
41536
American (AMR)
AF:
AC:
3158
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
AC:
949
AN:
3468
East Asian (EAS)
AF:
AC:
1386
AN:
5154
South Asian (SAS)
AF:
AC:
1562
AN:
4820
European-Finnish (FIN)
AF:
AC:
4274
AN:
10568
Middle Eastern (MID)
AF:
AC:
50
AN:
294
European-Non Finnish (NFE)
AF:
AC:
25520
AN:
67956
Other (OTH)
AF:
AC:
539
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1508
3017
4525
6034
7542
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
440
880
1320
1760
2200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
953
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 29, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.